TG Therapeutics Inc (TGTX) — Long-term Investment Intensity
TG Therapeutics Inc (TGTX) has a Long-term Investment Intensity of 4.8% as of September 2025. Long-term investments of $48.76 Million represent 4.8% of total assets of $1.03 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See TGTX total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
TG Therapeutics Inc Long-term Investment Intensity (2013–2024)
This chart shows how TG Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2013 to 2024. As of September 2025, the intensity stands at 4.8%, reflecting long-term investments of $48.76 Million against total assets of $1.03 Billion USD. Also explore TG Therapeutics Inc assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for TG Therapeutics Inc (2013–2024)
The table below presents the year-by-year Long-term Investment Intensity for TG Therapeutics Inc from 2013 to 2024, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see TG Therapeutics Inc (TGTX) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.1% | $808.00K | $577.69 Million | ▼ -6.3 pp |
| 2022 | 6.4% | $12.40 Million | $193.57 Million | ▼ -3.0 pp |
| 2021 | 9.4% | $35.53 Million | $379.63 Million | ▼ -12.7 pp |
| 2015 | 22.0% | $25.00 Million | $113.47 Million | ▲ +11.8 pp |
| 2013 | 10.2% | $4.92 Million | $48.11 Million | — |